What is a stock summary page? Click here for an overview.
Business Description
TMC Life Sciences Bhd
ISIN : MYQ0101OO004
Description
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.68 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 3.46 | |||||
| Interest Coverage | 1.72 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.23 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.1 | |||||
| 3-Year EBITDA Growth Rate | 29.4 | |||||
| 3-Year EPS without NRI Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.18 | |||||
| 9-Day RSI | 70.02 | |||||
| 14-Day RSI | 62.94 | |||||
| 3-1 Month Momentum % | -18.81 | |||||
| 6-1 Month Momentum % | -25.45 | |||||
| 12-1 Month Momentum % | -39.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.87 | |||||
| Cash Ratio | 1.25 | |||||
| Days Inventory | 44.11 | |||||
| Days Sales Outstanding | 58.42 | |||||
| Days Payable | 219.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.11 | |||||
| Dividend Payout Ratio | 0.63 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 1.11 | |||||
| 5-Year Yield-on-Cost % | 2.28 | |||||
| Shareholder Yield % | 3.08 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.64 | |||||
| Operating Margin % | 5.3 | |||||
| Net Margin % | 4.02 | |||||
| FCF Margin % | -1.5 | |||||
| ROE % | 1.48 | |||||
| ROA % | 1.1 | |||||
| ROIC % | 1.38 | |||||
| 3-Year ROIIC % | 26.76 | |||||
| ROC (Joel Greenblatt) % | 3.69 | |||||
| ROCE % | 2.47 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 55 | |||||
| PE Ratio without NRI | 55 | |||||
| Shiller PE Ratio | 6.96 | |||||
| PEG Ratio | 3.57 | |||||
| PS Ratio | 2.38 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 1.19 | |||||
| Price-to-Operating-Cash-Flow | 20.95 | |||||
| EV-to-EBIT | 31.06 | |||||
| EV-to-EBITDA | 14.55 | |||||
| EV-to-Revenue | 2.57 | |||||
| EV-to-FCF | -164.01 | |||||
| Price-to-GF-Value | 0.63 | |||||
| Price-to-Projected-FCF | 2.1 | |||||
| Price-to-DCF (Earnings Based) | 1.76 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.93 | |||||
| Price-to-Graham-Number | 1.69 | |||||
| Earnings Yield (Greenblatt) % | 3.22 | |||||
| FCF Yield % | -0.63 | |||||
| Forward Rate of Return (Yacktman) % | 14.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TMC Life Sciences Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 322.59 | ||
| EPS (TTM) (RM) | 0.008 | ||
| Beta | 0.46 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 14.87 | ||
| 14-Day RSI | 62.94 | ||
| 14-Day ATR (RM) | 0.013954 | ||
| 20-Day SMA (RM) | 0.40525 | ||
| 12-1 Month Momentum % | -39.26 | ||
| 52-Week Range (RM) | 0.365 - 0.755 | ||
| Shares Outstanding (Mil) | 1,741.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TMC Life Sciences Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TMC Life Sciences Bhd Stock Events
| Event | Date | Price (RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
TMC Life Sciences Bhd Frequently Asked Questions
What is TMC Life Sciences Bhd(XKLS:0101)'s stock price today?
The current price of XKLS:0101 is RM0.44. The 52 week high of XKLS:0101 is RM0.76 and 52 week low is RM0.37.
When is next earnings date of TMC Life Sciences Bhd(XKLS:0101)?
The next earnings date of TMC Life Sciences Bhd(XKLS:0101) is .
Does TMC Life Sciences Bhd(XKLS:0101) pay dividends? If so, how much?
The Dividend Yield %  of TMC Life Sciences Bhd(XKLS:0101) is 1.11% (As of Today), Highest Dividend Payout Ratio of TMC Life Sciences Bhd(XKLS:0101) was 0.63. The lowest was 0.08. And the median was 0.17. The  Forward Dividend Yield % of TMC Life Sciences Bhd(XKLS:0101) is 1.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers